Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Y-mAbs Therapeutics Inc YMAB

Healthcare Biotechnology
Y-mAbs Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of radioimmunotherapy and antibody-based therapeutic cancer products. The Company’s technologies include its investigational Self-Assembly DisAssembly (SADA) Pretargeted Radioimmunotherapy Platform (PRIT) and bispecific antibodies generated using the Y... see more

Current News (NDAQ:YMAB)

No current news is available.
View More News ››

Opinion & Analysis (NDAQ:YMAB)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:YMAB)

Buy buddy buy because this stock

Otherwise FOMO for you fellas out there so good luck to all shareholders today and
coolfooldumbguy - August 5, 2025

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) – Navigating t

http://beyondspx.com/2024/08/02/y-mabs-therapeutics-inc-nasdaqymab-navigating-the-complexities-of-antibody-based-cancer-treatments/
MikeTester - August 3, 2024

RE:nice results

The trend is our friend on this one.
Joe455 - April 1, 2022

nice results

sweet
Karren411 - March 28, 2022
View more Bullboard ››

SEGO Resources Inc.

SEGO Resources Inc.

Sego Resources Inc., an exploration stage company, engages in the acquisition, exploration, and evaluation of mineral ...
View More »

Podcasts